Effectiveness of Doxy-PEP for STI prevention in women questioned
TL;DR Summary
A treatment known as doxy-PEP, an antibiotic taken after unprotected sex, has shown promise in reducing the risk of sexually transmitted infections (STIs) like chlamydia and syphilis. However, a recent study found that it did not work in cisgender women, raising doubts about its effectiveness in this population. The study followed nearly 450 women in Kenya and found that adherence to the medication was low, with only about a third of the samples showing doxycycline presence. Further research is needed to understand why adherence was low and to determine if doxy-PEP is a viable option for women in preventing STIs.
- Doxy-PEP, a morning-after pill for STDs, may be less effective for women : Shots - Health News NPR
- Biomedical STI prevention evidence is inadequate for cisgender women National Institutes of Health (.gov)
- Doxycycline Prophylaxis to Prevent STIs in Women | NEJM nejm.org
- Antibiotic After Sex No Help in Preventing STIs in Women Medpage Today
- Survey gauges US healthcare provider views on doxy-PEP University of Minnesota Twin Cities
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 5 min read
Condensed
89%
906 → 100 words
Want the full story? Read the original article
Read on NPR